Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Sanjay Popat, Richard A Hubner, Richard S. Houlston · Journal of Clinical Oncology · 2005
PURPOSE: A number of studies have investigated the relationship between microsatellite instability (MSI) and colorectal cancer (CRC) prognosis. Although many have reported a better survival with MSI, estimates of the hazard ratio (HR) among studies differ. To derive a more precise estimate of the prognostic significance of MSI, we have reviewed and pooled data from published studies. METHODS: Studies stratifying survival in CRC patients by MSI status were eligible for analysis. The principal outcome measure was the HR. Data from eligible studies were pooled using standard techniques. RESULTS: Thirty-two eligible studies reported survival in a total of 7,642 cases, including 1,277 with MSI. There was no evidence of publication bias. The combined HR estimate for overall survival associated with MSI was 0.65 (95% CI, 0.59 to 0.71; heterogeneity P = .16; I(2) = 20%). This benefit was maintained restricting analyses to clinical trial patients (HR = 0.69; 95% CI, 0.56 to 0.85) and patients with locally advanced CRC (HR = 0.67; 95% CI, 0.58 to 0.78). In patients treated with adjuvant fluorouracil (FU) CRCs with MSI had a better prognosis (HR = 0.72; 95% CI, 0.61 to 0.84). However, while data are limited, tumors with MSI derived no benefit from adjuvant FU (HR = 1.24; 95% CI, 0.72 to 2.14). CONCLUSION: CRCs with MSI have a significantly better prognosis compared to those with intact mismatch repair. Additional studies are needed to further define the benefit of adjuvant chemotherapy in locally advanced tumors with MSI.
Cited by 1,830 works. doi:10.1200/jco.2005.01.086
Authors
References
- Meta-analysis in clinical trials
- Bias in meta-analysis detected by a simple, graphical test
- Quantifying heterogeneity in a meta‐analysis
- Meta-Analyses of Randomized Controlled Trials
- A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
- Microsatellite Instability in Cancer of the Proximal Colon
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
- Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
- A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma